February 11, 2000
Citing Patient's Death, Key Senator Urges Better Oversight of Gene-Therapy Trials
Congress may demand stricter oversight of gene-therapy researchers, following the death of a teenage patient during an experiment at the University of Pennsylvania in September. During a hearing last week, the chairman of the Senate Subcommittee on Public Health cited "a systemwide problem" in monitoring risks facing participants in such studies.
The subcommittee's chairman, Sen. Bill Frist -- a heart-transplant surgeon and Republican from Tennessee -- was especially critical of a
This content is only for subscribers. You can gain access by purchasing a:
Print Subscription
Digital Subscription
Already have an account? Log In Now.
-
Research
-
Linguistics
-
Advice
